BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25541973)

  • 1. The Dishevelled, EGL-10 and pleckstrin (DEP) domain-containing protein DEPDC7 binds to CARMA2 and CARMA3 proteins, and regulates NF-κB activation.
    D'Andrea EL; Ferravante A; Scudiero I; Zotti T; Reale C; Pizzulo M; De La Motte LR; De Maio C; Mazzone P; Telesio G; Vito P; Stilo R
    PLoS One; 2014; 9(12):e116062. PubMed ID: 25541973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CARD14/CARMA2 Signaling and its Role in Inflammatory Skin Disorders.
    Zotti T; Polvere I; Voccola S; Vito P; Stilo R
    Front Immunol; 2018; 9():2167. PubMed ID: 30319628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroepithelial transforming gene 1 (Net1) binds to caspase activation and recruitment domain (CARD)- and membrane-associated guanylate kinase-like domain-containing (CARMA) proteins and regulates nuclear factor κB activation.
    Vessichelli M; Ferravante A; Zotti T; Reale C; Scudiero I; Picariello G; Vito P; Stilo R
    J Biol Chem; 2012 Apr; 287(17):13722-30. PubMed ID: 22343628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis.
    Takeda K; Harada Y; Watanabe R; Inutake Y; Ogawa S; Onuki K; Kagaya S; Tanabe K; Kishimoto H; Abe R
    Int Immunol; 2008 Dec; 20(12):1507-15. PubMed ID: 18829987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
    Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
    Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and functional characterization of a BCL10-inhibitory peptide that represses NF-kappaB activation.
    Marasco D; Stilo R; Sandomenico A; Monti SM; Tizzano B; de Capua A; Varricchio E; Liguoro D; Zotti T; Formisano S; Ruvo M; Vito P
    Biochem J; 2009 Aug; 422(3):553-61. PubMed ID: 19538180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative splicing of CARMA2/CARD14 transcripts generates protein variants with differential effect on NF-κB activation and endoplasmic reticulum stress-induced cell death.
    Scudiero I; Zotti T; Ferravante A; Vessichelli M; Vito P; Stilo R
    J Cell Physiol; 2011 Dec; 226(12):3121-31. PubMed ID: 21302310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A20 is a negative regulator of BCL10- and CARMA3-mediated activation of NF-kappaB.
    Stilo R; Varricchio E; Liguoro D; Leonardi A; Vito P
    J Cell Sci; 2008 Apr; 121(Pt 8):1165-71. PubMed ID: 18349075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The E3 Ubiquitin Ligase RNF7 Negatively Regulates CARD14/CARMA2sh Signaling.
    Telesio G; Scudiero I; Pizzulo M; Mazzone P; Zotti T; Voccola S; Polvere I; Vito P; Stilo R
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CARMA2sh and ULK2 control pathogen-associated molecular patterns recognition in human keratinocytes: psoriasis-linked CARMA2sh mutants escape ULK2 censorship.
    Scudiero I; Mazzone P; D'Andrea LE; Ferravante A; Zotti T; Telesio G; De Rubis G; Reale C; Pizzulo M; Muralitharan S; Vito P; Stilo R
    Cell Death Dis; 2017 Feb; 8(2):e2627. PubMed ID: 28230860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of Carma1, but not Bcl10, by Akt regulates TCR/CD28-mediated NF-κB induction and cytokine production.
    Cheng J; Hamilton KS; Kane LP
    Mol Immunol; 2014 May; 59(1):110-6. PubMed ID: 24548923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CARMA3: Scaffold Protein Involved in NF-κB Signaling.
    Zhang S; Lin X
    Front Immunol; 2019; 10():176. PubMed ID: 30814996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CARMA3 Is a Critical Mediator of G Protein-Coupled Receptor and Receptor Tyrosine Kinase-Driven Solid Tumor Pathogenesis.
    McAuley JR; Freeman TJ; Ekambaram P; Lucas PC; McAllister-Lucas LM
    Front Immunol; 2018; 9():1887. PubMed ID: 30158935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CKIP-1 is an intrinsic negative regulator of T-cell activation through an interaction with CARMA1.
    Sakamoto T; Kobayashi M; Tada K; Shinohara M; Io K; Nagata K; Iwai F; Takiuchi Y; Arai Y; Yamashita K; Shindo K; Kadowaki N; Koyanagi Y; Takaori-Kondo A
    PLoS One; 2014; 9(1):e85762. PubMed ID: 24465689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical and functional interaction of CARMA1 and CARMA3 with Ikappa kinase gamma-NFkappaB essential modulator.
    Stilo R; Liguoro D; Di Jeso B; Formisano S; Consiglio E; Leonardi A; Vito P
    J Biol Chem; 2004 Aug; 279(33):34323-31. PubMed ID: 15184390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CBM Complex Underwrites NF-κB Activation to Promote HER2-Associated Tumor Malignancy.
    Pan D; Zhu Y; Zhou Z; Wang T; You H; Jiang C; Lin X
    Mol Cancer Res; 2016 Jan; 14(1):93-102. PubMed ID: 26392569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl10 is phosphorylated on Ser138 by Ca2+/calmodulin-dependent protein kinase II.
    Ishiguro K; Ando T; Goto H; Xavier R
    Mol Immunol; 2007 Mar; 44(8):2095-100. PubMed ID: 17052756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CARD9 versus CARMA1 in innate and adaptive immunity.
    Hara H; Saito T
    Trends Immunol; 2009 May; 30(5):234-42. PubMed ID: 19359218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Genetic Heterogeneity of
    Israel L; Mellett M
    Front Immunol; 2018; 9():2239. PubMed ID: 30386326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between BCL10, MALT1 and IkappaBalpha during T-cell-receptor-mediated NFkappaB activation.
    Carvalho G; Le Guelte A; Demian C; Vazquez A; Gavard J; Bidère N
    J Cell Sci; 2010 Jul; 123(Pt 14):2375-80. PubMed ID: 20551178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.